BioLife Solutions (BLFS) Misses Q3 EPS by 7c; Offers FY22 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil up about 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
BioLife Solutions Reports Third Quarter 2022 Financial Results
November 9, 2022 4:05 PM ESTRecord revenue of $40.7 million increased 21% over Q3 2021; biopreservation media revenue growth of 50%, validating leading position as a critical cell and gene therapies tool supplier
Cash flow from operations of $1.5 million and adjusted EBITDA of $1.4 million
Tightens 2022 revenue guidance range reflecting year-over-year growth of 34% to 38% and organic growth of 37% to 40%
Conference call begins at 4:30 p.m. Eastern time todayÂ
BOTHELL, Wash., Nov. 9, 2022 /PRNewswire/ --... More
